References
- Burman C, Kutcher GJ, Emami B, Goitein M. 1991. Fitting of normal tissue tolerance data to an analytic function. Int J Radiat Oncol Biol Phys. 21(1):123–135.
- Emami B, Lyman J, Brown A, Coia L, Goitein M, Munzenrider JE, Shank B, Solin LJ, Wesson M. 1991. Tolerance of normal tissue to therapeutic irradiation. Int J Radiat Oncol Biol Phys. 21(1):109–122.
- Fenwick JD. 2001. Impact of dose-distribution uncertainties on rectal ntcp modeling II: uncertainty implications. Med Phys. 28(4):570–581.
- Gronchi A, Casali PM, Mariani L, Lo VS, Bertulli R, Colecchia M, Lozza L, Olmi P, Santinami M, Rosai J. 2004. Retroperitoneal soft tissue sarcomas: patterns of recurrence in 167 patients treated at a single institution. Cancer. 100(11):2448–2455.
- Harald P, Blakely E, Carabe-Fernandez A, Carlson DJ, Das IJ, Dong L, Grosshans D, Held KD, Mohan R, Moiseenko V, Niemierko A, Stewart RD, Willers H. 2019. Report of the AAPM TG-256 on the relative biological effectiveness of proton beams in radiation therapy. Med Phys. 46(3):e53–e78.
- Jaques DP, Coit DG, Hajdu SI, Brennan MF. 1990. Management of primary and recurrent soft-tissue sarcoma of the retroperitoneum. Annals Surg. 212(1):51–59.
- Lee TF, Huang EY. 2014. The different dose-volume effects of normal tissue complication probability using LASSO for acute small-bowel toxicity during radiotherapy in gynecological patients with or without prior abdominal surgery. BioMed Res Int. 2014:143020.
- Luo C, Jin H, Miao C, Yang S, Yuanchun F. 2016. Experts consensus on diagnosis and treatment of retroperitoneal liposarcoma. Chinese J Minimally Invasive Surg. 16(12):1057–1063.
- Matthyssens LE, Creytens D, Ceelen WP. 2015. Retroperitoneal liposarcoma: current insights in diagnosis and treatment. Front Surg. 2:4.
- Mohindra P, Neuman HB, Kozak KR. 2013. The role of radiation in retroperitoneal sarcomas. Current Treatment Options Oncol. 14(3):425–441.
- Murphy JD, Christman-Skieller C, Kim J, Dieterich S, Chang DT, Koong AC. 2010. A dosimetric model of duodenal toxicity after stereotactic body radiotherapy for pancreatic cancer. Int J Radiat Oncol Biol Phys. 78(5):1420–1426.
- Olsen JR, Moughan J, Myerson RJ, Abitbol AA, Kunos C, Johnson DW, Schefter T, Chen Y, Fisher B, Michalski J et al. 2014. Predictors of radiotherapy-related GI toxicity from anal cancer DP-IMRT: secondary analysis of RTOG 0529. Int J Radiat Oncol Biol Phys. 90(1):S31.
- Sampath S, Hitchcock YJ, Shrieve DC, Randall RL, Schultheiss TE, Wong JY. 2010. Radiotherapy and extent of surgical resection in retroperitoneal soft-tissue sarcoma: multi-institutional analysis of 261 patients. J Surg Oncol. 101(5):345–350.
- Serizawa I, Kagei K, Kamada T, Imai R, Sugahara S, Okada T, Tsuji H, Ito H, Tsujii H. 2009. Carbon ion radiotherapy for unresectable retroperitoneal sarcomas. Int J Radiat Oncol Biol Phys. 75(4):1105–1110.
- Shinoto M, Shioyama Y, Matsunobu A, Okamoto K, Suefuji H, Toyama S, Honda H, Kudo S. 2016. Dosimetric analysis of upper gastrointestinal ulcer after carbon-ion radiotherapy for pancreatic cancer. Radiother Oncol. 120(1):140–144.
- Tuan J, Vitolo V, Vischioni B, Iannalfi A, Fiore MR, Fossati P, Orecchia R. 2014. Radiation therapy for retroperitoneal sarcoma. Radiol Med. 119(10):790–802.
- Wang W, Huang Z, Sheng Y, Zhao J, Shahnazi K, Zhang Q, Jiang G. 2020. RBE-weighted dose conversions for carbon ionradiotherapy between microdosimetric kinetic model and local effect model for the targets and organs at risk in prostate carcinoma. Radiother Oncol. 144:30–36.
- Yoon SS, Chen YL, Kirsch DG, Maduekwe UN, Rosenberg AE, Nielsen GP, Sahani DV, Choy E, Harmon DC, Delaney TF. 2010. Proton-beam, intensity-modulated, and/or intraoperative electron radiation therapy combined with aggressive anterior surgical resection for retroperitoneal sarcomas. Annals Surg Oncol. 17(6):1515–1529.
- Zagars GK, Ballo MT. 2003. Significance of dose in postoperative radiotherapy for soft tissue sarcoma. Int J Radiat Oncol Biol Phys. 56(2):473–481.